-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – APO-2 in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APO-2 in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. APO-2 in Diabetic Foot Ulcers Drug Details: APO-2 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RioDerm-001 in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RioDerm-001 in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RioDerm-001 in Diabetic Foot Ulcers Drug Details: RioDerm-001 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pravibismane in Diabetic Foot Infection (DFI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pravibismane in Diabetic Foot Infection (DFI) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pravibismane in Diabetic Foot Infection (DFI) Drug Details: Pravibismane (MBN-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Collagenase Clostridium Histolyticum in Hand, Foot and Mouth Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Collagenase Clostridium Histolyticum in Hand, Foot and Mouth Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Collagenase Clostridium Histolyticum in Hand, Foot and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adipose Tissue Derived Mesenchymal Stromal/Stem Cells...
-
Product Insights
Hand, Foot and Mouth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Drugs In Development, 2023’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Tinea Pedis (Athlete Foot) – Drugs In Development, 2023
Global Markets Direct’s, ‘Tinea Pedis (Athlete Foot) - Drugs In Development, 2023’, provides an overview of the Tinea Pedis (Athlete Foot) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tinea Pedis (Athlete Foot), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EscharEx in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EscharEx in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EscharEx in Diabetic Foot Ulcers Drug Details: EscharEx is under development...